BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 26631030)

  • 1. Genetic variants in IL12 influence both hepatitis B virus clearance and HBV-related hepatocellular carcinoma development in a Chinese male population.
    Tan A; Gao Y; Yao Z; Su S; Jiang Y; Xie Y; Xian X; Mo Z
    Tumour Biol; 2016 May; 37(5):6343-8. PubMed ID: 26631030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene polymorphisms of TLR2 and TLR3 in HBV clearance and HBV-related hepatocellular carcinoma in a Chinese male population.
    Chen D; Xie W; Lu Y; Su S; Nong L; Jia Y; Liu Y; Zhou W; Wang H; Tan A
    Int J Biol Markers; 2017 May; 32(2):e195-e201. PubMed ID: 28009434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL12 polymorphisms, HBV infection and risk of hepatocellular carcinoma in a high-risk Chinese population.
    Liu L; Xu Y; Liu Z; Chen J; Zhang Y; Zhu J; Liu J; Liu S; Ji G; Shi H; Shen H; Hu Z
    Int J Cancer; 2011 Apr; 128(7):1692-6. PubMed ID: 20521253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.
    Li S; Deng Y; Chen ZP; Huang S; Liao XC; Lin LW; Li H; Peng T; Qin X; Zhao JM
    Infect Genet Evol; 2011 Dec; 11(8):2083-8. PubMed ID: 22019522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development.
    Hu L; Zhai X; Liu J; Chu M; Pan S; Jiang J; Zhang Y; Wang H; Chen J; Shen H; Hu Z
    Hepatology; 2012 May; 55(5):1426-31. PubMed ID: 22105689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants in class II transactivator are associated with chronic hepatitis B virus infection in the Han Chinese population.
    Su M; Chen Z; Zheng J; Chen Y
    Int J Immunogenet; 2020 Oct; 47(5):435-442. PubMed ID: 32103629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between polymorphisms of the
    He XT; Xu HQ; Wang XM; He XS; Niu JQ; Gao PJ
    World J Gastroenterol; 2017 Jan; 23(2):232-241. PubMed ID: 28127197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-21 gene polymorphisms and chronic hepatitis B infection in a Chinese population.
    Yao JY; Chao K; Li MR; Wu YQ; Zhong BH
    World J Gastroenterol; 2015 Apr; 21(14):4232-9. PubMed ID: 25892873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between interleukin-21 gene polymorphisms (rs12508721) and HBV-related hepatocellular carcinoma.
    Zhang QX; Li SL; Yao YQ; Li TJ
    Int J Immunogenet; 2016 Jun; 43(3):151-8. PubMed ID: 27122304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PNPLA3 rs738409 is not associated with the risk of hepatocellular carcinoma and persistent infection of hepatitis B virus (HBV) in HBV-related subjects: A case-control study and meta-analysis on Asians.
    Wang P; Wu C; Li Y; Gong Y; Shen N
    Gene; 2020 Jun; 742():144585. PubMed ID: 32173542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UBE2L3, a susceptibility gene that plays oncogenic role in hepatitis B-related hepatocellular carcinoma.
    Liu Y; Song C; Ni H; Jiao W; Gan W; Dong X; Liu J; Zhu L; Zhai X; Hu Z; Li J
    J Viral Hepat; 2018 Nov; 25(11):1363-1371. PubMed ID: 29969176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDC25B is associated with the risk of hepatocellular carcinoma, but not related to persistent infection of hepatitis B virus in a Chinese population.
    Wang P; Peng J; Gong Y; Shen N
    Mol Biol Rep; 2020 May; 47(5):3361-3368. PubMed ID: 32248384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A genetic variant of the NTCP gene is associated with HBV infection status in a Chinese population.
    Yang J; Yang Y; Xia M; Wang L; Zhou W; Yang Y; Jiang Y; Wang H; Qian J; Jin L; Wang X
    BMC Cancer; 2016 Mar; 16():211. PubMed ID: 26968990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of single nucleotide polymorphisms in VDR and DBP genes with HBV-related hepatocellular carcinoma risk in a Chinese population.
    Peng Q; Yang S; Lao X; Li R; Chen Z; Wang J; Qin X; Li S
    PLoS One; 2014; 9(12):e116026. PubMed ID: 25541958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the GLB1 rs4678680 genetic variant with risk of HBV-related hepatocellular carcinoma.
    Wang WT; Li Z; Shi M; Zhu H; Xiong X; Shang J; Liu J; Teng M; Yang M
    Oncotarget; 2016 Aug; 7(35):56501-56507. PubMed ID: 27489354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of PINX1 but not TEP1 Polymorphisms with Progression to Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B Virus Infection.
    Sriprapun M; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Payungporn S; Tangkijvanich P
    Asian Pac J Cancer Prev; 2016; 17(4):2019-25. PubMed ID: 27221889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DR genetic polymorphisms and hepatitis B virus mutations affect the risk of hepatocellular carcinoma in Han Chinese population.
    Zhao Y; Chen K; Yang H; Zhang F; Ding L; Liu Y; Zhang L; Zhang Y; Wang H; Deng Y
    Virol J; 2023 Nov; 20(1):283. PubMed ID: 38037048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus genotypes, expression quantitative trait loci for ZNRD1-AS1 and their interactions in hepatocellular carcinoma.
    Liu Z; Song C; Wen J; Xu L; Liu Y; Zhu J; Zhu L; Hu Z; Ma H; Liu L
    Oncotarget; 2016 Jul; 7(28):44076-44083. PubMed ID: 27286450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Association of interleukin-12 gene polymorphism with persistence of hepatitis B virus infection and hepatocellular carcinoma].
    Park JS; Cheong JY; Kang JK; Cho JH; Yu S; Shin HD; Park BL; Cho SW
    Korean J Gastroenterol; 2007 Nov; 50(5):313-8. PubMed ID: 18159163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.